Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Breast Neoplasms 4Brain Neoplasms 2Thrombophilia 1Stomach Neoplasms 1Prostatic Neoplasms 1Patient Satisfaction 1Neoplasms 1Motor Activity 1Liver Neoplasms 1Liver Diseases 1Central Nervous System Neoplasms 1Breast Diseases 1Blood Coagulation Disorders 1

Interventions

Surveys and Questionnaires 34Blood Specimen Collection 24enzalutamide 18Radiotherapy 15Docetaxel 15Biopsy 14Abiraterone Acetate 14apalutamide 13Leuprolide 13Interviews as Topic 13Observation 12Magnetic Resonance Spectroscopy 12Watchful Waiting 10radium Ra 223 dichloride 9darolutamide 9Androgen Antagonists 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Radiosurgery 7Magnetic Resonance Imaging 7Brachytherapy 7abiraterone 6Specimen Handling 6Amplified Fragment Length Polymorphism Analysis 6Triptorelin Pamoate 5Standard of Care 5Positron Emission Tomography Computed Tomography 5Gonadotropin-Releasing Hormone 5Focus Groups 5Registries 4Radiotherapy, Intensity-Modulated 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Prostatic Neoplasms × Lead × Clear all
NCT07014618 2025-12-17

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

University of Oklahoma

Recruiting
420 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡